HR 4053 United States House · 118th Congress

Studying Suboxone Act

HR 4053, the Studying Suboxone Act, directs the U.S. Department of Health and Human Services (HHS) to review and update scientific evaluations of buprenorphine-naloxone medications (used to treat opioid addiction) and recommend updated scheduling under federal law. The Attorney General must then review HHS's findings, consider legal factors, and decide whether to adjust the medication's legal classification. This bill specifically affects the scheduling status of these medications, which impacts how they can be prescribed and distributed under federal drug laws. The process aims to ensure the scheduling aligns with current medical evidence, without changing treatment access or prescribing rules directly.

Bill status in committee 1 of 4 stages cleared

Introduction

Jun 2023

Committee Review

Floor Vote

President

Introduced Jun 13, 2023 Last action Jun 16, 2023

Floor votes

How they voted

No floor votes recorded yet.

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Jun 16, 2023

Committee

Referred to the Subcommittee on Health.

lower

Jun 13, 2023

Committee

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

lower

Jun 13, 2023

Introduced

Introduced in House

lower

1 primary · 3 co-sponsors